Insiders who reported open-market trades in the last 12 months at the companies Paul A. Friedman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
ORBIMED ADVISORS LLC - $12.50M in PRLD purchases and sales in the last 12 months
David P. Bonita - $12.50M in PRLD purchases and sales in the last 12 months
William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
Paul A. Friedman is a corporate insider of Prelude Therapeutics Inc (PRLD). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Paul A. Friedman last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 7 filings going back to 2025.
Has Paul A. Friedman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 39 open-market sales ($75.15M) across all tracked filings.
Paul A. Friedman files SEC Form 4 reports at Prelude Therapeutics Inc (PRLD). 7 SEC Form 4 filings on record going back to 2025, most recently on 10 June 2026. Most recent open-market trade: sold $1.56M of MDGL on 13 August 2025. Lifetime open-market sales: $75.15M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Paul A. Friedman.
InsiderAlpha's records for Paul A. Friedman go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
